Brief: Qlife Puts Development Of Two-In-One Test On Hold

Qlife Holding AB

18/11/2022 15:05

Nov 18 (Reuters) - Qlife Holding AB  QLIFE.ST :
    * QLIFE PUTS DEVELOPMENT OF TWO-IN-ONE TEST ON HOLD
    * DELAY IN FINALIZING DEVELOPMENT OF TWO-IN-ONE TEST FOR
INFLUENZA
AND SARS-COV-2 VIRUS ASSAY, AND ASSOCIATED TECHNICAL ADJUSTMENT
IN EGOO OPTICS, MEANS THAT THIS PROJECT HAS BEEN PUT ON HOLD
    * IMPLICATIONS OF DEVELOPMENT DELAY ARE THAT CLINICAL TRIAL
CANNOT
BE FINALIZED BEFORE END OF 2022, WHICH IN TURN MEANS THAT 3(RD)
PAYMENT WILL BE CANCELLED BY FIND UNDER PROJECT TERMS
    * IS IN CLOSE DIALOGUE WITH FIND TO CLARIFY WHETHER LAST
MILESTONE
OF 0.9 MUSD CAN BE PAID-OUT UPON COMPLETION IN 2023 INSTEAD

Source text for Eikon:  ID:nWkr6vG2Fd 
Further company coverage:  QLIFE.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))